Scientists at the IFOM-IEO Campus in Milan have recently uncovered a novel role for the neural adhesion molecule L1 in the regulation of the immune system. The discovery, published in the Journal of Experimental Medicine, paves the way for new therapies to treat autoimmune diseases, as well as metastatic cancers, such as colon cancer, melanoma and ovarian carcinoma.